• HIT-SIOP PNET 4 a prospective randomized controlled trial of hyperfractionated versus conventionally fractionated radiotherapy in standard risk medulloblastoma. (chiuso arruolamento ma ancora in uso in attesa nuovo protocollo)
  • Protocollo di diagnosi e cura del medulloblastoma metastatico e/o a istologia sfavorevole (HART)
  • 2° protocollo AIEOP di diagnosi e cura degli ependimomi dell'età pediatrica
  • SIOP-LGG 2004 cooperative multicenter study for children and adolescents with low grade glioma
  • Protocol CLDE225C2301 Novartis: A Phase III, multi-center, open-label, randomized,controlled study of the efficacy and safety of oral LDE225 versus temozolomide in patients with Hh-pathway activated relapsed medulloblastoma.
  • Protocol for treatment of CNS high risk malignant tumors in patients aged < 3 years
  • BO25041 / ITCC-019 / HGG-01: An open-label, randomized, multi-centre comparative study of bevacizumab-based therapy in paediatric patients with newly diagnosed supratentorial high-grade glioma.
  • Studio epidemiologico "MOBI-KIDS - Rischio di tumori cerebrali ed esposizione a campi elettromagnetici a radiofrequenza nei bambini e negli adolescenti: uno studio multicentrico internazionale.
  • European Rhabdoid Registry - EU-RHAB.
  • SIOP CNS GCT II: prospective trial for the diagnosis and treatment of children, adolescents and young adults with Intracranial Germ Cell Tumours.